Source: Virtual Congress 2021 – Highlights for primary care in 2021



Rating:

Share or cite this content

Citations should be made in the following way:
J. Kocks (Groningen, Netherlands), H. Wouters (Groningen, Netherlands), S. Bosnic-Anticevich (Sydney, Australia), J. Van Cooten (Groningen, Netherlands), J. Correia De Sousa (Braga, Portugal), B. Cvetkovski (Sydney, Australia), R. Dekhuijzen (Nijmegen, Netherlands), L. Dijk (Groningen, Netherlands), E. Dvortsin (Groningen, Netherlands), M. Garcia Pardo (Palma de Mallorca, Spain), A. Gardev (Ingelheim am Rhein, Germany), R. Gawlik (Katowice, Poland), I. Van Geer (Groningen, Netherlands), I. Van Der Ham (Groningen, Netherlands), M. Harbers (Groningen, Netherlands), A. De La Hoz (Ingelheim am Rhein, Germany), Y. Janse (Groningen, Netherlands), F. Lavorini (Florence, Italy), T. Maricoto (Covilha, Portugal), J. Meijer (Groningen, Netherlands), B. Metz (Groningen, Netherlands), D. Price (Singapore, Singapore), M. Roman Rodriguez (Palma de Mallorca, Spain), K. Schuttel (Groningen, Netherlands), N. Stoker (Groningen, Netherlands), I. Tsiligianni (Rethymno, Greece), O. Usmani (London, United Kingdom), M. Leving (Groningen, Netherlands). Late Breaking Abstract - Factors associated with health-status of COPD patients on Dry Powder Inhaler (DPI) maintenance therapy. 81

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Dry Powder Inhaler Preference in asthma patients. Results of the DPI PREFER Study Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Late Breaking Abstract - Lung deposition of two different ICS/LABA combinations with Dry Powder Inhaler (DPI) in asthmatic patients using Functional Respiratory Imaging (FRI). Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019 Late Breaking Abstract - Real-world evidence of dual bronchodilator therapy using Clinical COPD Questionnaire in 4700 COPD patients Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020 Late Breaking Abstract - Extrafine single inhaler triple therapy improves quality of life in COPD. Analysis of SGRQ subdomains of the TRIBUTE Study Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018 Late Breaking Abstract - Compare outcomes between COPD patients treated with Tiotropium/Olodaterol (TIO/OLO) and other fixed-dose LAMA/LABAs Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Late Breaking Abstract - Effectiveness of Fluticasone furoate/vilanterol (FF/VI) compared to usual care (UC) in patients with asthma: The Salford Lung Study (SLS) Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - Assessment of physical functioning and handling with Tiotropium/Olodaterol (T/O) in patients with COPD requiring long-acting dual bronchodilation in an Italian cohort of patients. Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Late Breaking Abstract - Pneumonia risk in COPD patients initiating extrafine Fixed Dose Combination (FDC) with beclometasone dipropionate (ef-FDC-BDP) versus long-acting bronchodilators (LABD) Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Evaluation of inhalation technique in patients using Dry Powder Inhaler (DPI), and the effect of patient education on their techniques- an experience from Nepal Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Late Breaking Abstract - Effects of a new Airway Clearance Technology versus manual physiotherapy in COPD Source: International Congress 2018 – Functional assessment of COPD Year: 2018 Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Late Breaking Abstract - COPD exacerbation benefits relative to pneumonia risk with budesonide/glycopyrronium/formoterol metered dose inhaler: analyses from ETHOS Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020 Late Breaking Abstract - Overestimation of asthma control and misperception of short-acting ß2-agonists (SABA) use among physicians in Poland Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 Preference, satisfaction and critical errors with Genuair® and Breezhaler® in patients with COPD Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 Late Breaking Abstract: Novel detection of exacerbations of COPD with patient reported outcome (EXACT-PRO) and Blackberry (BB) Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring Year: 2010 Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019 Inspiratory flow resistance of marketed dry powder inhalers (DPI) Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014